LyondellBasell (LYB) reported $10.32 billion in income for the quarter ended September 2024, representing a year-over-year decline of two.9%. EPS of $1.88 for a similar interval compares to $2.46 a yr in the past.
The reported income represents a shock of +0.49% over the Zacks Consensus Estimate of $10.27 billion. With the consensus EPS estimate being $2.03, the EPS shock was -7.39%.
Whereas buyers carefully watch year-over-year adjustments in headline numbers — income and earnings — and the way they examine to Wall Road expectations to find out their subsequent plan of action, some key metrics at all times present a greater perception into an organization’s underlying efficiency.
Since these metrics play a vital function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps buyers higher mission a inventory’s value efficiency.
Right here is how LyondellBasell carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Road analysts:
- Revenues- Superior Polymer Options: $896 million versus the four-analyst common estimate of $964.69 million. The reported quantity represents a year-over-year change of -0.3%.
- Revenues- Olefins and Polyolefins- Americas: $2.98 billion in comparison with the $3.04 billion common estimate based mostly on 4 analysts. The reported quantity represents a change of +3.5% yr over yr.
- Revenues- Olefins and Polyolefins- Europe, Asia, Worldwide: $2.81 billion versus the four-analyst common estimate of $2.81 billion. The reported quantity represents a year-over-year change of +14.8%.
- Revenues- Different/Eliminations: -$1.25 billion versus -$1.50 billion estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a -20.1% change.
- Revenues- Refining: $2.05 billion versus the four-analyst common estimate of $1.76 billion. The reported quantity represents a year-over-year change of -22.9%.
- Revenues- Know-how: $146 million versus $177.76 million estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a -33% change.
- Revenues- Intermediates & Derivatives: $2.69 billion in comparison with the $2.90 billion common estimate based mostly on 4 analysts. The reported quantity represents a change of -12.8% yr over yr.
- EBITDA- Olefins & Polyolefins- Americas: $758 million versus the four-analyst common estimate of $749.37 million.
- EBITDA- Olefins & Polyolefins- Europe, Asia, Worldwide: $81 million versus the four-analyst common estimate of $74.52 million.
- EBITDA- Superior Polymer Options: $19 million in comparison with the $38.45 million common estimate based mostly on 4 analysts.
- EBITDA- Know-how: $69 million versus the four-analyst common estimate of $109.17 million.
- EBITDA- Different: -$10 million versus the four-analyst common estimate of -$6.75 million.
View all Key Company Metrics for LyondellBasell here>>>
Shares of LyondellBasell have returned -8.5% over the previous month versus the Zacks S&P 500 composite’s -1% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it might carry out in step with the broader market within the close to time period.
Zacks’ Analysis Chief Names “Inventory Most Prone to Double”
Our staff of specialists has simply launched the 5 shares with the best chance of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This prime decide is among the many most revolutionary monetary corporations. With a fast-growing buyer base (already 50+ million) and a various set of innovative options, this inventory is poised for large positive aspects. After all, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Nano-X Imaging which shot up +129.6% in little greater than 9 months.
Free: See Our Top Stock And 4 Runners Up
LyondellBasell Industries N.V. (LYB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
